Table 3.
0.5% prevalence | 2% prevalence | 5% prevalence | ||||
---|---|---|---|---|---|---|
PPV | NPV | PPV | NPV | PPV | NPV | |
FDA | 1.6% | 99.9% | 6.2% | 99.7% | 14.6% | 99.3% |
AAO-HNS | 0.6% | 99.9% | 2.4% | 99.8% | 6.1% | 99.5% |
0.5% prevalence | 2% prevalence | 5% prevalence | ||||
---|---|---|---|---|---|---|
PPV | NPV | PPV | NPV | PPV | NPV | |
FDA | 1.6% | 99.9% | 6.2% | 99.7% | 14.6% | 99.3% |
AAO-HNS | 0.6% | 99.9% | 2.4% | 99.8% | 6.1% | 99.5% |